BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4871405)

  • 1. Selective suppression of cellular immunity by antilymphocyte serum.
    Lance EM; Batchelor JR
    Transplantation; 1968 May; 6(3):490-1. PubMed ID: 4871405
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antilymphocyte serum (ALS) on the secondary immune response in mice.
    Marshall VR; Knight PR
    Aust J Exp Biol Med Sci; 1969 Apr; 47(2):275-80. PubMed ID: 4978602
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological effects of antithymus serum and antilymphocyte serum.
    Nagaya H; Sieker HO
    Prog Immunobiol Stand; 1970; 4():225-9. PubMed ID: 4098263
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of the xenogeneic and allogeneic components of bivalent rabbit antilymphocyte serum.
    Stewart PB; Cohen V; Bell R
    Nature; 1969 May; 222(5193):592-3. PubMed ID: 4889309
    [No Abstract]   [Full Text] [Related]  

  • 5. Mode of action of antilymphocyte serum.
    DeMeester TR
    Surg Gynecol Obstet; 1969 Oct; 129(4):717-22. PubMed ID: 4898242
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterologous antilymphocyte sera and some of their effects.
    Russell PS; Monaco AP
    Transplantation; 1967 Jul; 5(4):Suppl:1086-99. PubMed ID: 4860603
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo antibody production by spleen cells after incubation in vitro with heterologous antilymphocyte plasma.
    Jeejeebhoy HF; Rabbat AG
    Nature; 1968 Dec; 220(5174):1350-2. PubMed ID: 4882918
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum.
    Stanbridge EJ; Perkins FT
    Nature; 1969 Jan; 221(5175):80-1. PubMed ID: 4882052
    [No Abstract]   [Full Text] [Related]  

  • 10. Erasure of immunological memory with anti-lymphocyte serum.
    Lance E
    Nature; 1968 Feb; 217(5128):557-8. PubMed ID: 4867972
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of action of antilymphocyte serum: effect on H-2 antibody formation, induction of allograft immunity, and tolerance to H-2 skin grafts.
    Franco DJ; Monaco AP
    Surg Forum; 1968; 19():175-7. PubMed ID: 4887902
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of the corneal homograft reaction by antilymphocyte serum.
    Smolin G
    Arch Ophthalmol; 1969 Apr; 81(4):571-6. PubMed ID: 4888031
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved graft survival after treatment with Bordetella and anti-lymphocyte serum.
    Ptak W; Festenstein H; Asherson GL; Denman AM
    Nature; 1969 Jun; 222(5198):1083-5. PubMed ID: 4306798
    [No Abstract]   [Full Text] [Related]  

  • 14. Antilymphocyte serum: summary and further observations.
    Woodruff MF
    Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract]   [Full Text] [Related]  

  • 15. The effectiveness of antisera raised against fractional antigens from murine thymocytes and lymphocytes.
    Hayes CR; Willard LF; Wilson RE
    Surg Forum; 1968; 19():180-2. PubMed ID: 4887903
    [No Abstract]   [Full Text] [Related]  

  • 16. Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat.
    James K; Anderson NF
    Clin Exp Immunol; 1968 Mar; 3(3):227-31. PubMed ID: 4872719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic antibodies after skin allotransplantation in rabbits.
    Matej H
    Arch Immunol Ther Exp (Warsz); 1970; 18(1):29-41. PubMed ID: 4908940
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
    Jeejeebhoy HF
    Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro demonstration of suppression of the efferent site in transplantation immunity with antilymphocyte serum.
    Tadakuma T; Watanabe S; Mitsuma T; Saito K
    Jpn J Microbiol; 1971 Jan; 15(1):105-8. PubMed ID: 4927837
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological enhancement.
    Russell PS
    Transplant Proc; 1971 Mar; 3(1):960-6. PubMed ID: 4941150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.